StonvexLoading…
StonvexStonvexStonvexCore line items from KMI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $15.20B | $13.48B | $13.65B | $18.13B |
Operating Income | $4.72B | $4.38B | $4.26B | $4.07B |
Net Income | $3.06B | $2.61B | $2.39B | $2.55B |
EPS (Diluted) | $1.37 | $1.17 | $1.06 | $1.12 |
Total Assets | $72.75B | $71.41B | $71.02B | $70.08B |
Total Liabilities | $40.30B | $39.54B | $39.29B | $37.96B |
Cash & Equivalents | $63.00M | $88.00M | $83.00M | $745.00M |
Free Cash Flow OCF − CapEx | $2.89B | $3.01B | $4.17B | $3.35B |
Shares Outstanding | 2.22B | 2.22B | 2.22B | 2.25B |